Suppr超能文献

相似文献

9
Highly potent triazole-based tubulin polymerization inhibitors.
J Med Chem. 2007 Feb 22;50(4):749-54. doi: 10.1021/jm061142s. Epub 2007 Jan 24.
10
Orally bioavailable tubulin antagonists for paclitaxel-refractory cancer.
Pharm Res. 2012 Nov;29(11):3053-63. doi: 10.1007/s11095-012-0814-5. Epub 2012 Jul 4.

引用本文的文献

1
Colchicine Binding Site Tubulin Inhibitors Impair Vincristine-Resistant Neuroblastoma Cell Function.
Molecules. 2025 May 16;30(10):2186. doi: 10.3390/molecules30102186.
2
Recent advances in zirconium-based catalysis and its applications in organic synthesis: a review.
RSC Adv. 2025 May 9;15(19):15417-15442. doi: 10.1039/d5ra01808k. eCollection 2025 May 6.
3
Fused Imidazopyrazine-Based Tubulin Polymerization Inhibitors Inhibit Neuroblastoma Cell Function.
ACS Med Chem Lett. 2023 Aug 25;14(9):1284-1294. doi: 10.1021/acsmedchemlett.3c00298. eCollection 2023 Sep 14.
4
Synthetic exploration of electrophilic xanthylation powerful -xanthylphthalimides.
Chem Sci. 2023 Aug 1;14(34):9197-9206. doi: 10.1039/d3sc03194b. eCollection 2023 Aug 30.
5
Synthesis of New Highly Functionalized 1-Indole-2-carbonitriles via Cross-Coupling Reactions.
Molecules. 2021 Aug 31;26(17):5287. doi: 10.3390/molecules26175287.
6
Thiazole-Based Thiosemicarbazones: Synthesis, Cytotoxicity Evaluation and Molecular Docking Study.
Drug Des Devel Ther. 2021 Feb 17;15:659-677. doi: 10.2147/DDDT.S291579. eCollection 2021.
8
Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review.
Pharmaceuticals (Basel). 2020 Jan 3;13(1):8. doi: 10.3390/ph13010008.
9
Nanoparticulate delivery of potent microtubule inhibitor for metastatic melanoma treatment.
J Control Release. 2019 Sep 10;309:231-243. doi: 10.1016/j.jconrel.2019.07.025. Epub 2019 Jul 19.
10
Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy.
Mol Pharmacol. 2019 Jul;96(1):73-89. doi: 10.1124/mol.118.114801. Epub 2019 May 1.

本文引用的文献

1
Biological activity of 4-substituted methoxybenzoyl-aryl-thiazole: an active microtubule inhibitor.
Cancer Res. 2011 Jan 1;71(1):216-24. doi: 10.1158/0008-5472.CAN-10-1725. Epub 2010 Nov 16.
3
Drug metabolism and pharmacokinetics of 4-substituted methoxybenzoyl-aryl-thiazoles.
Drug Metab Dispos. 2010 Nov;38(11):2032-9. doi: 10.1124/dmd.110.034348. Epub 2010 Jul 30.
4
A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer.
Br J Cancer. 2010 Apr 27;102(9):1355-60. doi: 10.1038/sj.bjc.6605650. Epub 2010 Apr 13.
6
ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature.
Anticancer Drugs. 2009 Jul;20(6):483-92. doi: 10.1097/CAD.0b013e32832c0acf.
8
A phase II study of ABT-751 in patients with advanced non-small cell lung cancer.
J Thorac Oncol. 2008 Jun;3(6):631-6. doi: 10.1097/JTO.0b013e318174e01f.
9
Recent progress in discovery and development of antimitotic agents.
Anticancer Agents Med Chem. 2007 Mar;7(2):189-208. doi: 10.2174/187152007780058650.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验